N-Power Medicine, Inc.

United States - Redwood City, California

• 02/07/2024
• Series B
• Undisclosed Amount

N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors.

The N-Power Platform consists of:
- The real-time Kaleido™ Registry, conducted with patient consent, that defines
standardized data collection at the point of care and is malleable to partner
needs,
- A technology solution that enables data collection and analysis, and
- Embedded on-site and virtual staff who support delivery of routine care,
implement standardized, registry protocol-defined data collection and augment
site staff in clinical research.

By partnering with oncologists, research staff and patients in unlocking the full potential of every patient’s data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development

Related People

Mark LeeFounder

United States - San Francisco Bay Area

I am a medical oncologist and scientist committed to bringing the transformative potential of meaningful data at scale and advanced analytics to accelerate the discovery, development, and delivery of new medicines and the personalization of patient care.

LinkedIn https://www.linkedin.com/in/mark-lee-07a8418/